Therefore, the inclusion of RIG-I in the panel of markers to evaluate the muscle biopsy can also be informative in ruling out the diagnosis of DM in muscle biopsies from patients with overlap syndromes showing PFA. The gene discussed is RIGI; the disease is dermatomyositis.